Literature DB >> 18559884

Pathogens causing recurrent and difficult-to-treat acute otitis media, 2003-2006.

Michael E Pichichero1, Janet R Casey, Alejandro Hoberman, Richard Schwartz.   

Abstract

This study sought to determine the microbiology of recurrent acute otitis media (AOM) and AOM treatment failure (AOMTF) in the context of widespread use of heptavalent pneumococcal conjugate vaccine (PCV7). In this retrospective cohort study, 244 AOM isolates obtained by tympanocentesis during 3 respiratory seasons--2003-2004 (n = 126), 2004-2005 (n = 52), 2005-2006 (n = 66)--from three geographically diverse pediatric populations were compared. Most isolates were from children less than 2 years old, who had received PCV7. For the 3 seasons the proportion of Streptococcus pneumoniae isolates was 35%, 35%, and 46% and for Haemophilus influenzae was 55%, 58%, and 39%, respectively (change in trend, P = .09). A total of 37%, 39%, and 50% of S. pneumoniae were penicillin nonsusceptible (PNSP) and 48%, 67%, and 50% of H. influenzae produced beta-lactamase, respectively. Although H. influenzae remains the most frequently isolated pathogen in children with AOMTF or recurrent AOM, S. pneumoniae that are PNSP are reemerging as important organisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18559884     DOI: 10.1177/0009922808319966

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  29 in total

1.  When co-colonizing the nasopharynx haemophilus influenzae predominates over Streptococcus pneumoniae except serotype 19A strains to cause acute otitis media.

Authors:  Qingfu Xu; Janet R Casey; Arthur Chang; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2012-06       Impact factor: 2.129

2.  Simultaneous assay for four bacterial species including Alloiococcus otitidis using multiplex-PCR in children with culture negative acute otitis media.

Authors:  Ravinder Kaur; Diana G Adlowitz; Janet R Casey; Mingtao Zeng; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2010-08       Impact factor: 2.129

3.  A new human colonization model for nontypeable Haemophilus influenzae.

Authors:  Stephen J Barenkamp
Journal:  J Infect Dis       Date:  2013-05-28       Impact factor: 5.226

4.  Naturally Acquired HMW1- and HMW2-Specific Serum Antibodies in Adults and Children Mediate Opsonophagocytic Killing of Nontypeable Haemophilus influenzae.

Authors:  Linda E Winter; Stephen J Barenkamp
Journal:  Clin Vaccine Immunol       Date:  2015-10-28

5.  Divergent mucosal and systemic responses in children in response to acute otitis media.

Authors:  D Verhoeven; M E Pichichero
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

6.  Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children.

Authors:  Ravinder Kaur; Janet R Casey; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2011-08       Impact factor: 2.129

7.  Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era.

Authors:  Ravinder Kaur; Matthew Morris; Michael E Pichichero
Journal:  Pediatrics       Date:  2017-08-07       Impact factor: 7.124

8.  Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae.

Authors:  Patricia L Winokur; Kathryn Chaloner; Gary V Doern; Jennifer Ferreira; Michael A Apicella
Journal:  J Infect Dis       Date:  2013-05-28       Impact factor: 5.226

9.  Resistance of Haemophilus influenzae to reactive nitrogen donors and gamma interferon-stimulated macrophages requires the formate-dependent nitrite reductase regulator-activated ytfE gene.

Authors:  Jane C Harrington; Sandy M S Wong; Charles V Rosadini; Oleg Garifulin; Victor Boyartchuk; Brian J Akerley
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

10.  Antibodies to the HMW1/HMW2 and Hia adhesins of nontypeable haemophilus influenzae mediate broad-based opsonophagocytic killing of homologous and heterologous strains.

Authors:  Linda E Winter; Stephen J Barenkamp
Journal:  Clin Vaccine Immunol       Date:  2014-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.